메뉴 건너뛰기




Volumn 16, Issue 2, 2002, Pages 23-24

Testing potential Alzheimer vaccines

(1)  Steinberg, Douglas a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords


EID: 23044530444     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (12)
  • 1
    • 0033536163 scopus 로고    scopus 로고
    • Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
    • D. Schenk et al., "Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse," Nature, 400:173-7, 1999.
    • (1999) Nature , vol.400 , pp. 173-177
    • Schenk, D.1
  • 2
    • 0033801852 scopus 로고    scopus 로고
    • Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease
    • H.L. Weiner et al., "Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease," Annals of Neurology, 48:567-79, 2000.
    • (2000) Annals of Neurology , vol.48 , pp. 567-579
    • Weiner, H.L.1
  • 3
    • 0034884382 scopus 로고    scopus 로고
    • Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
    • August
    • E.M. Sigurdsson et al., "Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice," American Journal of Pathology, 159[2]:439-47, August 2001.
    • (2001) American Journal of Pathology , vol.159 , Issue.2 , pp. 439-447
    • Sigurdsson, E.M.1
  • 4
    • 33746981279 scopus 로고    scopus 로고
    • "Development of plasmid DNA vaccines against beta amyloid protein for prophylactic and/or therapeutic use against transgenic mouse model of amyloid deposition,"poster #649.6, Abstracts from the SFN meeting
    • C. Cao et al., "Development of plasmid DNA vaccines against beta amyloid protein for prophylactic and/or therapeutic use against transgenic mouse model of amyloid deposition," poster #649.6, 2001 SFN meeting. Abstracts from the SFN meeting are available at www.sfn.org.
    • 2001 SFN Meeting
    • Cao, C.1
  • 5
    • 0033835996 scopus 로고    scopus 로고
    • Peripherally administered antibodies against amyloid b-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
    • F. Bard et al., "Peripherally administered antibodies against amyloid b-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease," Nature Medicine, 6:916-9, 2000.
    • (2000) Nature Medicine , vol.6 , pp. 916-919
    • Bard, F.1
  • 6
    • 33747014258 scopus 로고    scopus 로고
    • Multiple mechanisms are involved in clearance of amyloid-β by immunotherapy
    • slide presentation #687.7
    • B.J. Bacskai et al., "Multiple mechanisms are involved in clearance of amyloid-β by immunotherapy," slide presentation #687.7, 2001 SFN meeting.
    • 2001 SFN Meeting
    • Bacskai, B.J.1
  • 7
    • 0035902619 scopus 로고    scopus 로고
    • Peripheral anti-Abantibody alters CNS and plasma A clearance and decreases brain Ab burden in a mouse model of Alzheimer's disease
    • July 17
    • R.B. DeMattos et al., "Peripheral anti-Abantibody alters CNS and plasma A clearance and decreases brain Ab burden in a mouse model of Alzheimer's disease," Proceedings of the National Academy of Sciences, 98[15]:8850-5, July 17, 2001.
    • (2001) Proceedings of the National Academy of Sciences , vol.98 , Issue.15 , pp. 8850-8855
    • DeMattos, R.B.1
  • 8
    • 0034700471 scopus 로고    scopus 로고
    • Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
    • C. Janus et al., Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease," Nature, 408:979-82, 2000.
    • (2000) Nature , vol.408 , pp. 979-982
    • Janus, C.1
  • 9
    • 84984755327 scopus 로고    scopus 로고
    • Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
    • D. Morgan et al., "Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease," Nature, 408:982-5, 2000.
    • (2000) Nature , vol.408 , pp. 982-985
    • Morgan, D.1
  • 10
    • 33746960212 scopus 로고    scopus 로고
    • Passive immunization reverses memory deficits but not Alzheimer-like pathology in very old APPV
    • slide presentation #687.12
    • J.-C. Dodart et al., "Passive immunization reverses memory deficits but not Alzheimer-like pathology in very old APPV717F transgenic mice," slide presentation #687.12, 2001 SFN meeting.
    • 2001 SFN Meeting , vol.717
    • Dodart, J.-C.1
  • 11
    • 33746944966 scopus 로고    scopus 로고
    • Dementia associated with Aβ accumulation reversed with Ab antibodies
    • poster #546.10
    • L.A. Kotilinek et al., "Dementia associated with Aβ accumulation reversed with Ab antibodies," poster #546.10, 2001 SFN meeting.
    • 2001 SFN Meeting
    • Kotilinek, L.A.1
  • 12
    • 33746996464 scopus 로고    scopus 로고
    • Short-term Aβ vaccinations do not improve cognitive performance in aged, cognitively-impaired APP+PS1 transgenic mice
    • slide presentation #687.11
    • D. Morgan et al., "Short-term Aβ vaccinations do not improve cognitive performance in aged, cognitively-impaired APP+PS1 transgenic mice," slide presentation #687.11, 2001 SFN meeting.
    • 2001 SFN Meeting
    • Morgan, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.